Abstract:Healthcare‐associated infection with "ESKAPE" pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species) is a global health crisis due to their extensive intrinsic antibiotic resistance and the ability to quickly acquire resistance determinants. Alternative treatment options are required to combat this crisis, and one possibility is the use of bacteriophages, or viruses that strictly infect the pathogenic bacteria. Currently, there is a renaissance in research and development into the use of phages to target multi‐, extensively, and pan‐resistant bacterial infections in humans, known as phage therapy. Using A. baumannii as an example, this article describes the isolation and purification of bacteriophages from sewage and soil samples, as well as general methods used in phage research such as precipitation of phages using polyethylene glycol, host range analysis, single‐cell burst size determination, DNA extraction, and restriction fragment length polymorphism analysis. © 2022 National Research Council Canada. Current Protocols © 2022 Wiley Periodicals LLC. Reproduced with the permission of the Minister of Innovation, Science, and Industry. Basic Protocol 1: Isolation of bacteriophages against A. baumannii from sewage samples Alternate Protocol 1: Isolation of bacteriophages against A. baumannii from soil samples Support Protocol 1: Titering a bacteriophage stock Basic Protocol 2: Purification of phage to an axenic working stock Support Protocol 2: Liquid propagation of bacteriophage Basic Protocol 3: Host range analysis using the spot plate method Basic Protocol 4: Single burst size analysis Alternate Protocol 2: One‐step growth curve Basic Protocol 5: Precipitation of bacteriophage using PEG 6000 Basic Protocol 6: DNA extraction from dsDNA bacteriophages Basic Protocol 7: Restriction fragment length polymorphism analysis of novel phage genomes

Isolation, Purification, and Characterization of Leptophages

Bacteriophage Isolation, Purification, and Characterization Techniques Against Ubiquitous Opportunistic Pathogens

Characterization and Whole-Genome Sequencing of Broad-Host-range Salmonella-specific Bacteriophages for Bio-Control.

Bacteriophage Isolation and Characterization: Phages of Escherichia coli

Phages for Phage Therapy: Isolation, Characterization, and Host Range Breadth

Isolation and Characterization of Klebsiella Phages for Phage Therapy

2772. Isolation and Characterization of Lytic Bacteriophages Targeting Clinical Isolates of genus Enterobacter

Isolation and genetic analysis of an environmental bacteriophage: A 10-session laboratory series in molecular virology

Propagation, Purification, and Characterization of Bacteriophages for Phage Therapy

Isolation and characterization of lytic bacteriophages against enterohaemorrhagic Escherichia coli

Isolation and Characterization of Novel Phages Targeting Pathogenic <i>Klebsiella pneumoniae</i>

Purification of phage for therapeutic applications using high throughput anion exchange membrane chromatography

Isolation and characterization of pathogenic Escherichia coli bacteriophages from chicken and beef offal

Bacteriophage Removal from Infected Salmonella Cultures

Isolation, characterization and genomic analysis of a novel phage IME178 with lytic activity against Escherichia coli

Isolation and Characterization of Salmonella Bacteriophages as Potential Agents for Phage Therapy of Antibiotic-Resistant Intestinal Infections

Isolation and characterization of Salmonella enterica- and Escherichia coli-specific bacteriophages of the genus Epseptimavirus from wastewater in Minnesota

Isolation and Genomic Analysis of Escherichia Phage AUBRB02: Implications for Phage Therapy in Lebanon

Isolation of Phages for Phage Therapy: A Comparison of Spot Tests and Efficiency of Plating Analyses for Determination of Host Range and Efficacy

Rationalisation of the purification process for a phage active pharmaceutical ingredient

Isolation and Characterization of Novel Lytic Bacteriophages Infecting Carbapenem-Resistant Pathogenic Diarrheagenic and Uropathogenic Escherichia Coli